INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294 | -20.8% | 9,312 | +2.4% | 0.00% | 0.0% |
| Q2 2023 | $371 | -7.7% | 9,093 | -15.7% | 0.00% | 0.0% |
| Q1 2023 | $402 | -12.2% | 10,781 | -17.9% | 0.00% | -25.0% |
| Q4 2022 | $458 | -99.9% | 13,125 | +15.6% | 0.00% | -33.3% |
| Q3 2022 | $635,000 | +10.2% | 11,352 | +2.0% | 0.01% | +20.0% |
| Q2 2022 | $576,000 | -30.6% | 11,130 | -2.5% | 0.01% | -16.7% |
| Q1 2022 | $830,000 | -71.4% | 11,420 | -53.5% | 0.01% | -45.5% |
| Q4 2021 | $2,902,000 | +76.6% | 24,550 | +100.5% | 0.01% | -21.4% |
| Q3 2021 | $1,643,000 | -15.9% | 12,245 | +1.5% | 0.01% | -12.5% |
| Q2 2021 | $1,953,000 | +211.5% | 12,063 | +54.5% | 0.02% | -33.3% |
| Q1 2021 | $627,000 | +47.2% | 7,810 | -0.3% | 0.02% | +50.0% |
| Q4 2020 | $426,000 | – | 7,835 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |